Screener
DexCom DXCM Other, net
Other, net at other companies
Other financials
Where this comes from
Reported directly by DexCom in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The source filing: DexCom’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001093557-26-000073
| (In millions) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Financing activities | ||
| Net proceeds from issuance of common stock | 12.7 | 14.2 |
| Payments for taxes related to net share settlement of equity awards | (35.8) | — |
| Other financing activities | (1.9) | (1.7) |
| Net cash provided by (used in) financing activities | (25.0) | 12.5 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2.8) | 2.3 |
| Increase in cash, cash equivalents and restricted cash | 199.3 | 298.8 |
| Cash, cash equivalents and restricted cash, beginning of period | 919.1 | 607.3 |
Item 1. Financial Statements
FAQ
- What is DexCom's other, net?
- DexCom (DXCM) reported other, net of -$1.9M in Q1 2026.
- How has DexCom's other, net changed year-over-year?
- DexCom's other, net decreased by 11.8% year-over-year, from -$1.7M to -$1.9M.
- What is the long-term trend for DexCom's other, net?
- Over 4 years (2021 to 2025), DexCom's other, net has grown at a -8.3% compound annual growth rate (CAGR), from -$9.9M to -$7M.
- What does other, net mean?
- Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.
Ask your AI about DexCom's other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude